SEC Info℠  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Huaizhong Health Group, Inc. – ‘10-Q’ for 1/31/21 – ‘XML’

On:  Wednesday, 4/7/21, at 2:58pm ET   ·   For:  1/31/21   ·   Accession #:  1640334-21-798   ·   File #:  0-55369

Previous ‘10-Q’:  ‘10-Q’ on 8/10/20 for 7/31/20   ·   Next:  ‘10-Q’ on 6/14/21 for 4/30/21   ·   Latest:  ‘10-Q’ on 5/26/23 for 1/31/23

Find Words in Filings emoji
 		  in    Show  and   ↓Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 4/07/21  Huaizhong Health Group, Inc.      10-Q        1/31/21   25:813K                                   Pubco Reporting … Inc/FA

Quarterly Report   —   Form 10-Q
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Quarterly Report                                    HTML    173K 
 2: EX-31.1     Certification -- §302 - SOA'02                      HTML     14K 
 3: EX-32.1     Certification -- §906 - SOA'02                      HTML     10K 
10: R1          Cover                                               HTML     61K 
11: R2          Balance Sheets                                      HTML     44K 
12: R3          Balance Sheets (Parenthetical)                      HTML     18K 
13: R4          Statements of Operations (Unaudited)                HTML     42K 
14: R5          Statements of Changes in Stockholders Deficit       HTML     20K 
                (Unaudited)                                                      
15: R6          Statements of Cash Flows (Unaudited)                HTML     33K 
16: R7          Summary of Significant Accounting Policies          HTML     16K 
17: R8          Going Concern                                       HTML     14K 
18: R9          Related Party Transactions                          HTML     13K 
19: R10         Summary of Significant Accounting Policies          HTML     20K 
                (Policies)                                                       
20: R11         Going Concern (Details Narrative)                   HTML     12K 
21: R12         Related Party Transactions (Details Narrative)      HTML     12K 
23: XML         IDEA XML File -- Filing Summary                      XML     34K 
 9: XML         XBRL Instance -- huaizhong_10q_htm                   XML    113K 
22: EXCEL       IDEA Workbook of Financial Reports                  XLSX     18K 
 6: EX-101.CAL  XBRL Calculations -- abcd-20210131_cal               XML     45K 
 8: EX-101.DEF  XBRL Definitions -- abcd-20210131_def                XML     40K 
 5: EX-101.LAB  XBRL Labels -- abcd-20210131_lab                     XML    188K 
 7: EX-101.PRE  XBRL Presentations -- abcd-20210131_pre              XML    132K 
 4: EX-101.SCH  XBRL Schema -- abcd-20210131                         XSD     36K 
24: JSON        XBRL Instance as JSON Data -- MetaLinks               63±    86K 
25: ZIP         XBRL Zipped Folder -- 0001640334-21-000798-xbrl      Zip     38K

‘XML’   —   XBRL Instance — huaizhong_10q_htm

This Document is an XBRL XML File.

                                                                                                                                                                                
<?xml version="1.0" encoding="windows-1252"?>
<xbrl xmlns="http://www.xbrl.org/2003/instance" xmlns:abcd="http://huaizhong.com/20210131" xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:us-gaap="http://fasb.org/us-gaap/2019-01-31" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xlink="http://www.w3.org/1999/xlink">
<link:schemaRef xlink:href="abcd-20210131.xsd" xlink:type="simple"/>
<context id="From2020-11-01to2021-01-31">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001593204 </identifier>
</entity>
<period>
<startDate> 2020-11-01 </startDate>
<endDate> 2021-01-31 </endDate>
</period>
</context>
<context id="From2019-11-01to2020-10-31_abcd_SoleOfficerMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001593204 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis"> abcd:SoleOfficerMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2019-11-01 </startDate>
<endDate> 2020-10-31 </endDate>
</period>
</context>
<context id="From2020-11-01to2021-01-31_abcd_SoleOfficerMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001593204 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis"> abcd:SoleOfficerMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2020-11-01 </startDate>
<endDate> 2021-01-31 </endDate>
</period>
</context>
<context id="AsOf2021-01-31_us-gaap_RetainedEarningsMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001593204 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:RetainedEarningsMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2021-01-31 </instant>
</period>
</context>
<context id="AsOf2021-01-31_us-gaap_AdditionalPaidInCapitalMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001593204 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:AdditionalPaidInCapitalMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2021-01-31 </instant>
</period>
</context>
<context id="AsOf2021-01-31_us-gaap_CommonStockMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001593204 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:CommonStockMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2021-01-31 </instant>
</period>
</context>
<context id="From2020-11-01to2021-01-31_us-gaap_RetainedEarningsMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001593204 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:RetainedEarningsMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2020-11-01 </startDate>
<endDate> 2021-01-31 </endDate>
</period>
</context>
<context id="From2020-11-01to2021-01-31_us-gaap_AdditionalPaidInCapitalMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001593204 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:AdditionalPaidInCapitalMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2020-11-01 </startDate>
<endDate> 2021-01-31 </endDate>
</period>
</context>
<context id="From2020-11-01to2021-01-31_us-gaap_CommonStockMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001593204 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:CommonStockMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2020-11-01 </startDate>
<endDate> 2021-01-31 </endDate>
</period>
</context>
<context id="AsOf2020-10-31_us-gaap_RetainedEarningsMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001593204 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:RetainedEarningsMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2020-10-31 </instant>
</period>
</context>
<context id="AsOf2020-10-31_us-gaap_AdditionalPaidInCapitalMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001593204 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:AdditionalPaidInCapitalMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2020-10-31 </instant>
</period>
</context>
<context id="AsOf2020-10-31_us-gaap_CommonStockMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001593204 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:CommonStockMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2020-10-31 </instant>
</period>
</context>
<context id="AsOf2020-01-31">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001593204 </identifier>
</entity>
<period>
<instant> 2020-01-31 </instant>
</period>
</context>
<context id="AsOf2020-01-31_us-gaap_RetainedEarningsMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001593204 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:RetainedEarningsMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2020-01-31 </instant>
</period>
</context>
<context id="AsOf2020-01-31_us-gaap_AdditionalPaidInCapitalMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001593204 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:AdditionalPaidInCapitalMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2020-01-31 </instant>
</period>
</context>
<context id="AsOf2020-01-31_us-gaap_CommonStockMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001593204 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:CommonStockMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2020-01-31 </instant>
</period>
</context>
<context id="From2019-11-01to2020-01-31_us-gaap_RetainedEarningsMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001593204 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:RetainedEarningsMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2019-11-01 </startDate>
<endDate> 2020-01-31 </endDate>
</period>
</context>
<context id="From2019-11-01to2020-01-31_us-gaap_AdditionalPaidInCapitalMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001593204 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:AdditionalPaidInCapitalMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2019-11-01 </startDate>
<endDate> 2020-01-31 </endDate>
</period>
</context>
<context id="From2019-11-01to2020-01-31_us-gaap_CommonStockMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001593204 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:CommonStockMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2019-11-01 </startDate>
<endDate> 2020-01-31 </endDate>
</period>
</context>
<context id="AsOf2019-10-31">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001593204 </identifier>
</entity>
<period>
<instant> 2019-10-31 </instant>
</period>
</context>
<context id="AsOf2019-10-31_us-gaap_RetainedEarningsMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001593204 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:RetainedEarningsMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2019-10-31 </instant>
</period>
</context>
<context id="AsOf2019-10-31_us-gaap_AdditionalPaidInCapitalMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001593204 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:AdditionalPaidInCapitalMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2019-10-31 </instant>
</period>
</context>
<context id="AsOf2019-10-31_us-gaap_CommonStockMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001593204 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:CommonStockMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2019-10-31 </instant>
</period>
</context>
<context id="From2019-11-01to2020-01-31">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001593204 </identifier>
</entity>
<period>
<startDate> 2019-11-01 </startDate>
<endDate> 2020-01-31 </endDate>
</period>
</context>
<context id="AsOf2020-10-31">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001593204 </identifier>
</entity>
<period>
<instant> 2020-10-31 </instant>
</period>
</context>
<context id="AsOf2021-01-31">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001593204 </identifier>
</entity>
<period>
<instant> 2021-01-31 </instant>
</period>
</context>
<context id="AsOf2021-04-07">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001593204 </identifier>
</entity>
<period>
<instant> 2021-04-07 </instant>
</period>
</context>
<unit id="USD">
<measure> iso4217:USD </measure>
</unit>
<unit id="Shares">
<measure> shares </measure>
</unit>
<unit id="USDPShares">
<divide>
<unitNumerator>
<measure> iso4217:USD </measure>
</unitNumerator>
<unitDenominator>
<measure> shares </measure>
</unitDenominator>
</divide>
</unit>
<dei:EntityCentralIndexKey contextRef="From2020-11-01to2021-01-31"> 0001593204 </dei:EntityCentralIndexKey>
<dei:AmendmentFlag contextRef="From2020-11-01to2021-01-31"> false </dei:AmendmentFlag>
<dei:CurrentFiscalYearEndDate contextRef="From2020-11-01to2021-01-31"> --10-31 </dei:CurrentFiscalYearEndDate>
<dei:DocumentFiscalPeriodFocus contextRef="From2020-11-01to2021-01-31"> Q1 </dei:DocumentFiscalPeriodFocus>
<dei:DocumentFiscalYearFocus contextRef="From2020-11-01to2021-01-31"> 2021 </dei:DocumentFiscalYearFocus>
<dei:EntityExTransitionPeriod contextRef="From2020-11-01to2021-01-31"> false </dei:EntityExTransitionPeriod>
<us-gaap:CommonStockParOrStatedValuePerShare contextRef="AsOf2020-10-31" decimals="INF" unitRef="USDPShares"> 0.001 </us-gaap:CommonStockParOrStatedValuePerShare>
<us-gaap:CommonStockSharesAuthorized contextRef="AsOf2020-10-31" decimals="0" unitRef="Shares"> 750000000 </us-gaap:CommonStockSharesAuthorized>
<us-gaap:CommonStockSharesIssued contextRef="AsOf2020-10-31" decimals="0" unitRef="Shares"> 31518466 </us-gaap:CommonStockSharesIssued>
<us-gaap:CommonStockSharesOutstanding contextRef="AsOf2020-10-31" decimals="0" unitRef="Shares"> 31518466 </us-gaap:CommonStockSharesOutstanding>
<us-gaap:CommonStockSharesOutstanding contextRef="AsOf2021-01-31" decimals="0" unitRef="Shares"> 31518466 </us-gaap:CommonStockSharesOutstanding>
<dei:DocumentType contextRef="From2020-11-01to2021-01-31"> 10-Q </dei:DocumentType>
<dei:DocumentQuarterlyReport contextRef="From2020-11-01to2021-01-31"> true </dei:DocumentQuarterlyReport>
<dei:DocumentPeriodEndDate contextRef="From2020-11-01to2021-01-31"> 2021-01-31 </dei:DocumentPeriodEndDate>
<dei:DocumentTransitionReport contextRef="From2020-11-01to2021-01-31"> false </dei:DocumentTransitionReport>
<dei:EntityFileNumber contextRef="From2020-11-01to2021-01-31"> 000-55369 </dei:EntityFileNumber>
<dei:EntityRegistrantName contextRef="From2020-11-01to2021-01-31"> HUAIZHONG HEALTH GROUP, INC. </dei:EntityRegistrantName>
<dei:EntityIncorporationStateCountryCode contextRef="From2020-11-01to2021-01-31"> NV </dei:EntityIncorporationStateCountryCode>
<dei:EntityTaxIdentificationNumber contextRef="From2020-11-01to2021-01-31"> 90-1020141 </dei:EntityTaxIdentificationNumber>
<dei:EntityAddressAddressLine1 contextRef="From2020-11-01to2021-01-31"> Tianan Technology Park </dei:EntityAddressAddressLine1>
<dei:EntityAddressAddressLine2 contextRef="From2020-11-01to2021-01-31"> 13/F Headquarters Center Building 16 </dei:EntityAddressAddressLine2>
<dei:EntityAddressAddressLine3 contextRef="From2020-11-01to2021-01-31"> 555 Panyu North Ave </dei:EntityAddressAddressLine3>
<dei:EntityAddressCityOrTown contextRef="From2020-11-01to2021-01-31"> Guangzhou City </dei:EntityAddressCityOrTown>
<dei:EntityAddressCountry contextRef="From2020-11-01to2021-01-31"> CN </dei:EntityAddressCountry>
<dei:CityAreaCode contextRef="From2020-11-01to2021-01-31"> 86 </dei:CityAreaCode>
<dei:LocalPhoneNumber contextRef="From2020-11-01to2021-01-31"> 2982 9356 </dei:LocalPhoneNumber>
<dei:EntityCurrentReportingStatus contextRef="From2020-11-01to2021-01-31"> Yes </dei:EntityCurrentReportingStatus>
<dei:EntityInteractiveDataCurrent contextRef="From2020-11-01to2021-01-31"> Yes </dei:EntityInteractiveDataCurrent>
<dei:EntityFilerCategory contextRef="From2020-11-01to2021-01-31"> Non-accelerated Filer </dei:EntityFilerCategory>
<dei:EntitySmallBusiness contextRef="From2020-11-01to2021-01-31"> true </dei:EntitySmallBusiness>
<dei:EntityEmergingGrowthCompany contextRef="From2020-11-01to2021-01-31"> true </dei:EntityEmergingGrowthCompany>
<dei:EntityShellCompany contextRef="From2020-11-01to2021-01-31"> true </dei:EntityShellCompany>
<dei:EntityCommonStockSharesOutstanding contextRef="AsOf2021-04-07" decimals="INF" unitRef="Shares"> 31518466 </dei:EntityCommonStockSharesOutstanding>
<us-gaap:Cash contextRef="AsOf2021-01-31" decimals="0" id="fid_2" unitRef="USD"> 0 </us-gaap:Cash>
<us-gaap:Cash contextRef="AsOf2020-10-31" decimals="0" id="fid_3" unitRef="USD"> 0 </us-gaap:Cash>
<us-gaap:AssetsCurrent contextRef="AsOf2021-01-31" decimals="0" id="fid_4" unitRef="USD"> 0 </us-gaap:AssetsCurrent>
<us-gaap:AssetsCurrent contextRef="AsOf2020-10-31" decimals="0" id="fid_5" unitRef="USD"> 0 </us-gaap:AssetsCurrent>
<us-gaap:Assets contextRef="AsOf2021-01-31" decimals="0" id="fid_6" unitRef="USD"> 0 </us-gaap:Assets>
<us-gaap:Assets contextRef="AsOf2020-10-31" decimals="0" id="fid_7" unitRef="USD"> 0 </us-gaap:Assets>
<us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent contextRef="AsOf2021-01-31" decimals="0" id="fid_10" unitRef="USD"> 10010 </us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
<us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent contextRef="AsOf2020-10-31" decimals="0" id="fid_11" unitRef="USD"> 10913 </us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
<us-gaap:DueToRelatedPartiesCurrent contextRef="AsOf2021-01-31" decimals="0" id="fid_12" unitRef="USD"> 20747 </us-gaap:DueToRelatedPartiesCurrent>
<us-gaap:DueToRelatedPartiesCurrent contextRef="AsOf2020-10-31" decimals="0" id="fid_13" unitRef="USD"> 8559 </us-gaap:DueToRelatedPartiesCurrent>
<us-gaap:LiabilitiesCurrent contextRef="AsOf2021-01-31" decimals="0" id="fid_14" unitRef="USD"> 30757 </us-gaap:LiabilitiesCurrent>
<us-gaap:LiabilitiesCurrent contextRef="AsOf2020-10-31" decimals="0" id="fid_15" unitRef="USD"> 19472 </us-gaap:LiabilitiesCurrent>
<us-gaap:Liabilities contextRef="AsOf2021-01-31" decimals="0" id="fid_16" unitRef="USD"> 30757 </us-gaap:Liabilities>
<us-gaap:Liabilities contextRef="AsOf2020-10-31" decimals="0" id="fid_17" unitRef="USD"> 19472 </us-gaap:Liabilities>
<us-gaap:CommonStockSharesAuthorized contextRef="AsOf2021-01-31" decimals="0" id="fid_58" unitRef="Shares"> 750000000 </us-gaap:CommonStockSharesAuthorized>
<us-gaap:CommonStockParOrStatedValuePerShare contextRef="AsOf2021-01-31" decimals="3" id="fid_56" unitRef="USDPShares"> 0.001 </us-gaap:CommonStockParOrStatedValuePerShare>
<us-gaap:CommonStockSharesIssued contextRef="AsOf2021-01-31" decimals="0" id="fid_61" unitRef="Shares"> 31518466 </us-gaap:CommonStockSharesIssued>
<us-gaap:CommonStockValue contextRef="AsOf2021-01-31" decimals="0" id="fid_19" unitRef="USD"> 31518 </us-gaap:CommonStockValue>
<us-gaap:CommonStockValue contextRef="AsOf2020-10-31" decimals="0" id="fid_20" unitRef="USD"> 31518 </us-gaap:CommonStockValue>
<us-gaap:AdditionalPaidInCapital contextRef="AsOf2021-01-31" decimals="0" id="fid_21" unitRef="USD"> 257587 </us-gaap:AdditionalPaidInCapital>
<us-gaap:AdditionalPaidInCapital contextRef="AsOf2020-10-31" decimals="0" id="fid_22" unitRef="USD"> 257587 </us-gaap:AdditionalPaidInCapital>
<us-gaap:RetainedEarningsAccumulatedDeficit contextRef="AsOf2021-01-31" decimals="0" id="fid_23" unitRef="USD"> -319862 </us-gaap:RetainedEarningsAccumulatedDeficit>
<us-gaap:RetainedEarningsAccumulatedDeficit contextRef="AsOf2020-10-31" decimals="0" id="fid_24" unitRef="USD"> -308577 </us-gaap:RetainedEarningsAccumulatedDeficit>
<us-gaap:StockholdersEquity contextRef="AsOf2021-01-31" decimals="0" id="fid_25" unitRef="USD"> -30757 </us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="AsOf2020-10-31" decimals="0" id="fid_26" unitRef="USD"> -19472 </us-gaap:StockholdersEquity>
<us-gaap:LiabilitiesAndStockholdersEquity contextRef="AsOf2021-01-31" decimals="0" id="fid_27" unitRef="USD"> 0 </us-gaap:LiabilitiesAndStockholdersEquity>
<us-gaap:LiabilitiesAndStockholdersEquity contextRef="AsOf2020-10-31" decimals="0" id="fid_28" unitRef="USD"> 0 </us-gaap:LiabilitiesAndStockholdersEquity>
<us-gaap:Revenues contextRef="From2020-11-01to2021-01-31" decimals="0" id="fid_29" unitRef="USD"> 0 </us-gaap:Revenues>
<us-gaap:Revenues contextRef="From2019-11-01to2020-01-31" decimals="0" id="fid_30" unitRef="USD"> 0 </us-gaap:Revenues>
<us-gaap:ProfessionalFees contextRef="From2020-11-01to2021-01-31" decimals="0" id="fid_32" unitRef="USD"> 9610 </us-gaap:ProfessionalFees>
<us-gaap:ProfessionalFees contextRef="From2019-11-01to2020-01-31" decimals="0" id="fid_33" unitRef="USD"> 5318 </us-gaap:ProfessionalFees>
<us-gaap:GeneralAndAdministrativeExpense contextRef="From2020-11-01to2021-01-31" decimals="0" id="fid_34" unitRef="USD"> 1675 </us-gaap:GeneralAndAdministrativeExpense>
<us-gaap:GeneralAndAdministrativeExpense contextRef="From2019-11-01to2020-01-31" decimals="0" id="fid_35" unitRef="USD"> 0 </us-gaap:GeneralAndAdministrativeExpense>
<us-gaap:OperatingExpenses contextRef="From2020-11-01to2021-01-31" decimals="0" id="fid_36" unitRef="USD"> 11285 </us-gaap:OperatingExpenses>
<us-gaap:OperatingExpenses contextRef="From2019-11-01to2020-01-31" decimals="0" id="fid_37" unitRef="USD"> 5318 </us-gaap:OperatingExpenses>
<us-gaap:OperatingIncomeLoss contextRef="From2020-11-01to2021-01-31" decimals="0" id="fid_38" unitRef="USD"> -11285 </us-gaap:OperatingIncomeLoss>
<us-gaap:OperatingIncomeLoss contextRef="From2019-11-01to2020-01-31" decimals="0" id="fid_39" unitRef="USD"> -5318 </us-gaap:OperatingIncomeLoss>
<us-gaap:InterestExpenseRelatedParty contextRef="From2020-11-01to2021-01-31" decimals="0" id="fid_41" unitRef="USD"> 0 </us-gaap:InterestExpenseRelatedParty>
<us-gaap:InterestExpenseRelatedParty contextRef="From2019-11-01to2020-01-31" decimals="0" id="fid_42" unitRef="USD"> 115 </us-gaap:InterestExpenseRelatedParty>
<us-gaap:OtherExpenses contextRef="From2020-11-01to2021-01-31" decimals="0" id="fid_43" unitRef="USD"> 0 </us-gaap:OtherExpenses>
<us-gaap:OtherExpenses contextRef="From2019-11-01to2020-01-31" decimals="0" id="fid_44" unitRef="USD"> 115 </us-gaap:OtherExpenses>
<us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="From2020-11-01to2021-01-31" decimals="0" id="fid_45" unitRef="USD"> -11285 </us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
<us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="From2019-11-01to2020-01-31" decimals="0" id="fid_46" unitRef="USD"> -5433 </us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
<us-gaap:IncomeTaxExpenseBenefit contextRef="From2020-11-01to2021-01-31" decimals="0" id="fid_47" unitRef="USD"> 0 </us-gaap:IncomeTaxExpenseBenefit>
<us-gaap:IncomeTaxExpenseBenefit contextRef="From2019-11-01to2020-01-31" decimals="0" id="fid_48" unitRef="USD"> 0 </us-gaap:IncomeTaxExpenseBenefit>
<us-gaap:NetIncomeLoss contextRef="From2020-11-01to2021-01-31" decimals="0" id="fid_49" unitRef="USD"> -11285 </us-gaap:NetIncomeLoss>
<us-gaap:NetIncomeLoss contextRef="From2019-11-01to2020-01-31" decimals="0" id="fid_50" unitRef="USD"> -5433 </us-gaap:NetIncomeLoss>
<us-gaap:EarningsPerShareBasicAndDiluted contextRef="From2020-11-01to2021-01-31" decimals="2" id="fid_51" unitRef="USDPShares"> -0.00 </us-gaap:EarningsPerShareBasicAndDiluted>
<us-gaap:EarningsPerShareBasicAndDiluted contextRef="From2019-11-01to2020-01-31" decimals="2" id="fid_52" unitRef="USDPShares"> -0.01 </us-gaap:EarningsPerShareBasicAndDiluted>
<us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted contextRef="From2020-11-01to2021-01-31" decimals="0" id="fid_53" unitRef="Shares"> 31518466 </us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
<us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted contextRef="From2019-11-01to2020-01-31" decimals="0" id="fid_54" unitRef="Shares"> 517853 </us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
<us-gaap:SharesIssued contextRef="AsOf2020-10-31_us-gaap_CommonStockMember" decimals="0" id="fid_65" unitRef="Shares"> 31518466 </us-gaap:SharesIssued>
<us-gaap:StockholdersEquity contextRef="AsOf2020-10-31_us-gaap_CommonStockMember" decimals="0" id="fid_66" unitRef="USD"> 31518 </us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="AsOf2020-10-31_us-gaap_AdditionalPaidInCapitalMember" decimals="0" id="fid_67" unitRef="USD"> 257587 </us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="AsOf2020-10-31_us-gaap_RetainedEarningsMember" decimals="0" id="fid_68" unitRef="USD"> -308577 </us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="AsOf2020-10-31" decimals="0" id="fid_69" unitRef="USD"> -19472 </us-gaap:StockholdersEquity>
<us-gaap:NetIncomeLoss contextRef="From2020-11-01to2021-01-31_us-gaap_CommonStockMember" decimals="0" id="fid_70" unitRef="USD"> 0 </us-gaap:NetIncomeLoss>
<us-gaap:NetIncomeLoss contextRef="From2020-11-01to2021-01-31_us-gaap_AdditionalPaidInCapitalMember" decimals="0" id="fid_71" unitRef="USD"> 0 </us-gaap:NetIncomeLoss>
<us-gaap:NetIncomeLoss contextRef="From2020-11-01to2021-01-31_us-gaap_RetainedEarningsMember" decimals="0" id="fid_72" unitRef="USD"> -11285 </us-gaap:NetIncomeLoss>
<us-gaap:NetIncomeLoss contextRef="From2020-11-01to2021-01-31" decimals="0" id="fid_73" unitRef="USD"> -11285 </us-gaap:NetIncomeLoss>
<us-gaap:SharesIssued contextRef="AsOf2021-01-31_us-gaap_CommonStockMember" decimals="0" id="fid_74" unitRef="Shares"> 31518466 </us-gaap:SharesIssued>
<us-gaap:StockholdersEquity contextRef="AsOf2021-01-31_us-gaap_CommonStockMember" decimals="0" id="fid_75" unitRef="USD"> 31518 </us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="AsOf2021-01-31_us-gaap_AdditionalPaidInCapitalMember" decimals="0" id="fid_76" unitRef="USD"> 257587 </us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="AsOf2021-01-31_us-gaap_RetainedEarningsMember" decimals="0" id="fid_77" unitRef="USD"> -319862 </us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="AsOf2021-01-31" decimals="0" id="fid_78" unitRef="USD"> -30757 </us-gaap:StockholdersEquity>
<us-gaap:SharesIssued contextRef="AsOf2019-10-31_us-gaap_CommonStockMember" decimals="0" id="fid_79" unitRef="Shares"> 517853 </us-gaap:SharesIssued>
<us-gaap:StockholdersEquity contextRef="AsOf2019-10-31_us-gaap_CommonStockMember" decimals="0" id="fid_80" unitRef="USD"> 518 </us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="AsOf2019-10-31_us-gaap_AdditionalPaidInCapitalMember" decimals="0" id="fid_81" unitRef="USD"> 250482 </us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="AsOf2019-10-31_us-gaap_RetainedEarningsMember" decimals="0" id="fid_82" unitRef="USD"> -272097 </us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="AsOf2019-10-31" decimals="0" id="fid_83" unitRef="USD"> -21097 </us-gaap:StockholdersEquity>
<us-gaap:NetIncomeLoss contextRef="From2019-11-01to2020-01-31_us-gaap_CommonStockMember" decimals="0" id="fid_84" unitRef="USD"> 0 </us-gaap:NetIncomeLoss>
<us-gaap:NetIncomeLoss contextRef="From2019-11-01to2020-01-31_us-gaap_AdditionalPaidInCapitalMember" decimals="0" id="fid_85" unitRef="USD"> 0 </us-gaap:NetIncomeLoss>
<us-gaap:NetIncomeLoss contextRef="From2019-11-01to2020-01-31_us-gaap_RetainedEarningsMember" decimals="0" id="fid_86" unitRef="USD"> -5433 </us-gaap:NetIncomeLoss>
<us-gaap:NetIncomeLoss contextRef="From2019-11-01to2020-01-31" decimals="0" id="fid_87" unitRef="USD"> -5433 </us-gaap:NetIncomeLoss>
<us-gaap:SharesIssued contextRef="AsOf2020-01-31_us-gaap_CommonStockMember" decimals="0" id="fid_88" unitRef="Shares"> 517853 </us-gaap:SharesIssued>
<us-gaap:StockholdersEquity contextRef="AsOf2020-01-31_us-gaap_CommonStockMember" decimals="0" id="fid_89" unitRef="USD"> 518 </us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="AsOf2020-01-31_us-gaap_AdditionalPaidInCapitalMember" decimals="0" id="fid_90" unitRef="USD"> 250482 </us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="AsOf2020-01-31_us-gaap_RetainedEarningsMember" decimals="0" id="fid_91" unitRef="USD"> -277530 </us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="AsOf2020-01-31" decimals="0" id="fid_92" unitRef="USD"> -26530 </us-gaap:StockholdersEquity>
<us-gaap:NetIncomeLoss contextRef="From2020-11-01to2021-01-31" decimals="0" id="fid_94" unitRef="USD"> -11285 </us-gaap:NetIncomeLoss>
<us-gaap:NetIncomeLoss contextRef="From2019-11-01to2020-01-31" decimals="0" id="fid_95" unitRef="USD"> -5433 </us-gaap:NetIncomeLoss>
<abcd:RelatedPartyAdvancesFundingOperations contextRef="From2020-11-01to2021-01-31" decimals="0" id="fid_97" unitRef="USD"> 12188 </abcd:RelatedPartyAdvancesFundingOperations>
<abcd:RelatedPartyAdvancesFundingOperations contextRef="From2019-11-01to2020-01-31" decimals="0" id="fid_98" unitRef="USD"> 5280 </abcd:RelatedPartyAdvancesFundingOperations>
<us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities contextRef="From2020-11-01to2021-01-31" decimals="0" id="fid_99" unitRef="USD"> -903 </us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities>
<us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities contextRef="From2019-11-01to2020-01-31" decimals="0" id="fid_100" unitRef="USD"> 153 </us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities>
<us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="From2020-11-01to2021-01-31" decimals="0" id="fid_101" unitRef="USD"> 0 </us-gaap:NetCashProvidedByUsedInOperatingActivities>
<us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="From2019-11-01to2020-01-31" decimals="0" id="fid_102" unitRef="USD"> 0 </us-gaap:NetCashProvidedByUsedInOperatingActivities>
<us-gaap:CashPeriodIncreaseDecrease contextRef="From2020-11-01to2021-01-31" decimals="0" id="fid_103" unitRef="USD"> 0 </us-gaap:CashPeriodIncreaseDecrease>
<us-gaap:CashPeriodIncreaseDecrease contextRef="From2019-11-01to2020-01-31" decimals="0" id="fid_104" unitRef="USD"> 0 </us-gaap:CashPeriodIncreaseDecrease>
<us-gaap:Cash contextRef="AsOf2020-10-31" decimals="0" id="fid_105" unitRef="USD"> 0 </us-gaap:Cash>
<us-gaap:Cash contextRef="AsOf2019-10-31" decimals="0" id="fid_106" unitRef="USD"> 0 </us-gaap:Cash>
<us-gaap:Cash contextRef="AsOf2021-01-31" decimals="0" id="fid_107" unitRef="USD"> 0 </us-gaap:Cash>
<us-gaap:Cash contextRef="AsOf2020-01-31" decimals="0" id="fid_108" unitRef="USD"> 0 </us-gaap:Cash>
<us-gaap:IncomeTaxesPaidNet contextRef="From2020-11-01to2021-01-31" decimals="0" id="fid_110" unitRef="USD"> 0 </us-gaap:IncomeTaxesPaidNet>
<us-gaap:IncomeTaxesPaidNet contextRef="From2019-11-01to2020-01-31" decimals="0" id="fid_111" unitRef="USD"> 0 </us-gaap:IncomeTaxesPaidNet>
<us-gaap:InterestPaidNet contextRef="From2020-11-01to2021-01-31" decimals="0" id="fid_112" unitRef="USD"> 0 </us-gaap:InterestPaidNet>
<us-gaap:InterestPaidNet contextRef="From2019-11-01to2020-01-31" decimals="0" id="fid_113" unitRef="USD"> 0 </us-gaap:InterestPaidNet>
<us-gaap:SignificantAccountingPoliciesTextBlock contextRef="From2020-11-01to2021-01-31" id="fid_128">
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>NOTE 1 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong><em>Basis of Presentation of Unaudited Interim Financial Statements</em></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The accompanying unaudited interim financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America for interim financial information and with the instructions to Form 10-Q and Regulation S-X. Accordingly, the unaudited interim financial statements do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">In the opinion of management, all adjustments consisting of normal recurring entries necessary for a fair statement of the periods presented for: (a) the financial position; (b) the result of operations; and (c) cash flows, have been made in order to make the unaudited interim financial statements presented not misleading. The results of operations for such interim periods are not necessarily indicative of operations for a full year. The accompanying unaudited interim financial statements should be read in conjunction with the financial statements and related notes included in the Company’s Annual Report on Form 10-K, for the year ended October 31, 2020, as filed with the SEC on March 22, 2021.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong><em>Use of Estimates </em></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements. The estimates and judgments will also affect the reported amounts for certain expenses during the reporting period. Actual results could differ from these good faith estimates and judgments.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">A novel strain of coronavirus (COVID-19) was first identified in December 2019, and subsequently declared a global pandemic by the World Health Organization on March 11, 2020. As a result of the outbreak, many companies have experienced disruptions in their operations and in markets served. The Company considered the impact of COVID-19 on the assumptions and estimates used and determined that there were no material adverse impacts on the Company’s results of operations and financial position at January 31, 2021. The full extent of the future impacts of COVID-19 on the Company’s operations is uncertain. A prolonged outbreak could have a material adverse impact on financial results and business operations of the Company, including the timing and ability of the Company to develop its business plan.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong><em>Reclassification</em></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Certain accounts from prior periods have been reclassified to conform to the current period presentation.</p>
</us-gaap:SignificantAccountingPoliciesTextBlock>
<us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock contextRef="From2020-11-01to2021-01-31" id="fid_131">
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The accompanying unaudited interim financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America for interim financial information and with the instructions to Form 10-Q and Regulation S-X. Accordingly, the unaudited interim financial statements do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">In the opinion of management, all adjustments consisting of normal recurring entries necessary for a fair statement of the periods presented for: (a) the financial position; (b) the result of operations; and (c) cash flows, have been made in order to make the unaudited interim financial statements presented not misleading. The results of operations for such interim periods are not necessarily indicative of operations for a full year. The accompanying unaudited interim financial statements should be read in conjunction with the financial statements and related notes included in the Company’s Annual Report on Form 10-K, for the year ended October 31, 2020, as filed with the SEC on March 22, 2021.</p>
</us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock>
<us-gaap:UseOfEstimates contextRef="From2020-11-01to2021-01-31" id="fid_132">
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements. The estimates and judgments will also affect the reported amounts for certain expenses during the reporting period. Actual results could differ from these good faith estimates and judgments.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">A novel strain of coronavirus (COVID-19) was first identified in December 2019, and subsequently declared a global pandemic by the World Health Organization on March 11, 2020. As a result of the outbreak, many companies have experienced disruptions in their operations and in markets served. The Company considered the impact of COVID-19 on the assumptions and estimates used and determined that there were no material adverse impacts on the Company’s results of operations and financial position at January 31, 2021. The full extent of the future impacts of COVID-19 on the Company’s operations is uncertain. A prolonged outbreak could have a material adverse impact on financial results and business operations of the Company, including the timing and ability of the Company to develop its business plan.</p>
</us-gaap:UseOfEstimates>
<abcd:Reclassification contextRef="From2020-11-01to2021-01-31" id="fid_133">
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Certain accounts from prior periods have been reclassified to conform to the current period presentation.</p>
</abcd:Reclassification>
<us-gaap:SubstantialDoubtAboutGoingConcernTextBlock contextRef="From2020-11-01to2021-01-31" id="fid_129">
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>NOTE 2 - </strong><strong>GOING CONCERN</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The accompanying financial statements have been prepared assuming that the Company will continue as a going concern, which contemplates the realization of assets and the liquidation of liabilities in the normal course of business. As of January 31, 2021, the Company has suffered recurring losses from operations, has an accumulated deficit of $319,862 and has not earned any revenues. The Company intends to fund operations through equity financing arrangements and related party advances, which may be insufficient to fund its capital expenditures, working capital and other cash requirements for the year ending October 31, 2022.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The ability of the Company to emerge from an early stage is dependent upon, among other things, obtaining additional financing to continue operations, and development of its business plan. In response to these problems, management intends to raise additional funds through public or private placement offerings.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">   </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">These factors, among others, raise substantial doubt about the Company’s ability to continue as a going concern. The accompanying financial statements do not include any adjustments that might result from the outcome of this uncertainty</p>
</us-gaap:SubstantialDoubtAboutGoingConcernTextBlock>
<us-gaap:RetainedEarningsAccumulatedDeficit contextRef="AsOf2021-01-31" decimals="0" id="fid_116" unitRef="USD"> -319862 </us-gaap:RetainedEarningsAccumulatedDeficit>
<us-gaap:RelatedPartyTransactionsDisclosureTextBlock contextRef="From2020-11-01to2021-01-31" id="fid_130">
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>NOTE 3 - RELATED PARTY TRANSACTIONS</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">During the three months ended January 31, 2021, the Company’s sole officer advanced to the Company an amount of $12,188 by paying for expenses on behalf of the Company. As of January 31, 2021, and October 31, 2020, the Company was obligated to the officer, for an unsecured, non-interest-bearing demand loan with a balance of $20,747 and $8,559, respectively.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em>Other</em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company does not own or lease property or lease office space. The office space used by the Company was arranged by the founder, who is also the CEO and President, of the Company to use at no charge.</p>
</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
<abcd:ExpensesPaidOnTheBehalfOfCompany contextRef="From2020-11-01to2021-01-31_abcd_SoleOfficerMember" decimals="0" id="fid_125" unitRef="USD"> 12188 </abcd:ExpensesPaidOnTheBehalfOfCompany>
<abcd:NonInterestBearingDemandLoan contextRef="From2020-11-01to2021-01-31_abcd_SoleOfficerMember" decimals="0" id="fid_126" unitRef="USD"> 20747 </abcd:NonInterestBearingDemandLoan>
<abcd:NonInterestBearingDemandLoan contextRef="From2019-11-01to2020-10-31_abcd_SoleOfficerMember" decimals="0" id="fid_127" unitRef="USD"> 8559 </abcd:NonInterestBearingDemandLoan>
</xbrl>

↑Top
Filing Submission 0001640334-21-000798   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)
Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
About — Privacy — Redactions — Help — Tue., Apr. 30, 1:42:18.1pm ET